Advertisement

Surfactant Deficiency Disorders: SP-B and ABCA3

  • Lawrence M. Nogee
Chapter
Part of the Respiratory Medicine book series (RM)

Abstract

Single gene disorders disrupting surfactant metabolism and resulting in acute and chronic lung disease have been identified in recent years. This review focuses on lung disease resulting from mutations in the genes encoding surfactant protein B (SP-B) and member A3 of the ATP-binding cassette (ABCA3) family of membrane transporters. The roles of these proteins in surfactant metabolism is reviewed, along with the epidemiology, molecular genetics, clinical features, natural history, lung pathology findings, approach to diagnosis, and treatment of the disorders resulting from mutations in these genes. Irreversible neonatal hypoxemic respiratory failure due to diffuse parenchymal lung disease is a common presentation of both disorders. Children with ABCA3 mutations may also present with relatively milder disease and findings of interstitial lung disease. While rare, these disorders result in significant respiratory morbidity and mortality, have provided insights into normal surfactant metabolism, and implicate these genes as having a role in more common lung diseases.

Keywords

newborn respiratory distress syndrome persistent pulmonary hypertension of the newborn interstitial lung disease surfactant protein genetic basis of disease alveolar proteinosis lung transplantation 

References

  1. 1.
    Farrell PM, Avery ME. Hyaline membrane disease. Am Rev Respir Dis 1975;111:657–88.PubMedGoogle Scholar
  2. 2.
    Jobe AH, Ikegami M. Surfactant and acute lung injury. Proc Assoc Am Physicians 1998;110:489–95.PubMedGoogle Scholar
  3. 3.
    Malloy MH, Freeman DH. Respiratory distress syndrome mortality in the United States, 1987 to 1995. J Perinatol 2000;20:414–20.PubMedCrossRefGoogle Scholar
  4. 4.
    Hamvas A, Cole FS, Nogee LM. Genetic disorders of surfactant proteins. Neonatology 2007;91:311–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Nogee LM. Genetics of pediatric interstitial lung disease. Curr Opin Pediatr 2006;18:287–92.PubMedCrossRefGoogle Scholar
  6. 6.
    Nogee LM. Genetic mechanisms of surfactant deficiency. Biol Neonate 2004;85:314–18.PubMedCrossRefGoogle Scholar
  7. 7.
    Nogee LM. Alterations in SP-B and SP-C expression in neonatal lung disease. Annu Rev Physiol 2004;66:601–23.PubMedCrossRefGoogle Scholar
  8. 8.
    Jobe AH, Ikegami M. Biology of surfactant. Clin Perinatol 2001;28:655–69, vii–viii.PubMedCrossRefGoogle Scholar
  9. 9.
    Andreeva AV, Kutuzov MA, Voyno-Yasenetskaya TA. Regulation of surfactant secretion in alveolar type II cells. Am J Physiol Lung Cell Mol Physiol 2007;293:L259–L71.PubMedCrossRefGoogle Scholar
  10. 10.
    Dietl P, Haller T, Mair N, Frick M. Mechanisms of surfactant exocytosis in alveolar type II cells in vitro and in vivo. News Physiol Sci 2001;16:239–43.PubMedGoogle Scholar
  11. 11.
    Mason RJ. Biology of alveolar type II cells. Respirology 2006;11 Suppl:S12–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Williams MC. Conversion of lamellar body membranes into tubular myelin in alveoli of fetal rat lungs. J Cell Biol 1977;72:260–77.PubMedCrossRefGoogle Scholar
  13. 13.
    Williams MC. Ultrastructure of tubular myelin and lamellar bodies in fast-frozen adult rat lung. Exp Lung Res 1982;4:37–46.PubMedCrossRefGoogle Scholar
  14. 14.
    Veldhuizen R, Possmayer F. Phospholipid metabolism in lung surfactant. Subcell Biochem 2004;37:359–88.PubMedGoogle Scholar
  15. 15.
    Weaver TE, Conkright JJ. Function of surfactant proteins B and C. Annu Rev Physiol 2001;63:555–78.PubMedCrossRefGoogle Scholar
  16. 16.
    Crouch E, Wright JR. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 2001;63:521–54.PubMedCrossRefGoogle Scholar
  17. 17.
    Floros J, Hoover RR. Genetics of the hydrophilic surfactant proteins A and D. Biochim Biophys Acta 1998;1408:312–22.PubMedGoogle Scholar
  18. 18.
    Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 2005;5:58–68.PubMedCrossRefGoogle Scholar
  19. 19.
    Nogee LM. Genetics of the hydrophobic surfactant proteins. Biochim Biophys Acta 1998;1408:323–33.PubMedGoogle Scholar
  20. 20.
    Whitsett JA, Ohning BL, Ross G, Meuth J, Weaver T, Holm BA, Shapiro DL, Notter RH. Hydrophobic surfactant-associated protein in whole lung surfactant and its importance for biophysical activity in lung surfactant extracts used for replacement therapy. Pediatr Res 1986;20:460–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Dean M. The genetics of ATP-binding cassette transporters. Meth Enzymol 2005;400:409–29.PubMedCrossRefGoogle Scholar
  22. 22.
    Dean M, Hamon Y, Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 2001;42:1007–17.PubMedGoogle Scholar
  23. 23.
    Zen K, Notarfrancesco K, Oorschot V, Slot JW, Fisher AB, Shuman H. Generation and characterization of monoclonal antibodies to alveolar type II cell lamellar body membrane. Am J Physiol 1998;275:L172–83.PubMedGoogle Scholar
  24. 24.
    Mulugeta S, Gray JM, Notarfrancesco KL, Gonzales LW, Koval M, Feinstein SI, Ballard PL, Fisher AB, Shuman H. Identification of LBM180, a lamellar body limiting membrane protein of alveolar type II cells, as the ABC transporter protein ABCA3. J Biol Chem 2002;277:22147–55.PubMedCrossRefGoogle Scholar
  25. 25.
    Allikmets R, Gerrard B, Hutchinson A, Dean M. Characterization of the human ABC superfamily: Isolation and mapping of 21 new genes using the expressed sequence tags database. Hum Mol Genet 1996;5:1649–55.PubMedCrossRefGoogle Scholar
  26. 26.
    Dean M, Allikmets R. Complete characterization of the human ABC gene family. J Bioenerg Biomembr 2001;33:475–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Cheong N, Madesh M, Gonzales LW, Zhao M, Yu K, Ballard PL, Shuman H. Functional and trafficking defects in ATP binding cassette A3 mutants associated with respiratory distress syndrome. J Biol Chem 2006;281:9791–800.PubMedCrossRefGoogle Scholar
  28. 28.
    Garmany TH, Moxley MA, White FV, Dean M, Hull WM, Whitsett JA, Nogee LM, Hamvas A. Surfactant composition and function in patients with ABCA3 mutations. Pediatr Res 2006;59:801–5.PubMedCrossRefGoogle Scholar
  29. 29.
    Matsumura Y, Sakai H, Sasaki M, Ban N, Inagaki N. ABCA3-mediated choline-phospholipids uptake into intracellular vesicles in A549 cells. FEBS Lett 2007;581:3139–44.PubMedCrossRefGoogle Scholar
  30. 30.
    Shulenin S, Nogee LM, Annilo T, Wert SE, Whitsett JA, Dean M. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med 2004;350:1296–303.PubMedCrossRefGoogle Scholar
  31. 31.
    Bullard JE, Wert SE, Whitsett JA, Dean M, Nogee LM. ABCA3 mutations associated with pediatric interstitial lung disease. Am J Respir Crit Care Med 2005;172:1026–31.PubMedCrossRefGoogle Scholar
  32. 32.
    Callaghan WM, MacDorman MF, Rasmussen SA, Qin C, Lackritz EM. The contribution of preterm birth to infant mortality rates in the United States. Pediatrics 2006;118:1566–73.PubMedCrossRefGoogle Scholar
  33. 33.
    Clark RH. The epidemiology of respiratory failure in neonates born at an estimated gestational age of 34 weeks or more. J Perinatol 2005;25:251–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Conrad SA, Rycus PT, Dalton H. Extracorporeal life support registry report 2004. Asaio J 2005;51:4–10.Google Scholar
  35. 35.
    Deutsch GH, Young LR, Deterding RR, Fan LL, Dell SD, Bean JA, Brody AS, Nogee LM, Trapnell BC, Langston C, et al. Diffuse lung disease in young children: Application of a novel classification scheme. Am J Respir Crit Care Med 2007;176:1120–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Nogee LM, Garnier G, Dietz HC, Singer L, Murphy AM, deMello DE, Colten HR. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 1994;93:1860–3.PubMedCrossRefGoogle Scholar
  37. 37.
    Tredano M, Griese M, de Blic J, Lorant T, Houdayer C, Schumacher S, Cartault F, Capron F, Boccon-Gibod L, Lacaze-Masmonteil T, et al. Analysis of 40 sporadic or familial neonatal and pediatric cases with severe unexplained respiratory distress: Relationship to SFTPB. Am J Med Genet A 2003;119:324–39.CrossRefGoogle Scholar
  38. 38.
    Hamvas A, Trusgnich M, Brice H, Baumgartner J, Hong Y, Nogee LM, Cole FS. Population-based screening for rare mutations: High-throughput DNA extraction and molecular amplification from Guthrie cards. Pediatr Res 2001;50:666–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Cole FS, Hamvas A, Rubinstein P, King E, Trusgnich M, Nogee LM, deMello DE, Colten HR. Population-based estimates of surfactant protein B deficiency. Pediatrics 2000;105:538–41.PubMedCrossRefGoogle Scholar
  40. 40.
    Garmany TH, Wambach JA, Heins HB, Watkins-Torry JM, Wegner DJ, Bennet K, An P, Land G, Saugstad OD, Henderson H, et al. Population and disease-based prevalence of the common mutations associated with surfactant deficiency. Pediatr Res 2008;63(6):645–9.PubMedCrossRefGoogle Scholar
  41. 41.
    Tredano M, Cooper DN, Stuhrmann M, Christodoulou J, Chuzhanova NA, Roudot-Thoraval F, Boelle PY, Elion J, Jeanpierre M, Feingold J, et al. Origin of the prevalent SFTPB indel g.1549C > GAA (121ins2) mutation causing surfactant protein B (SP-B) deficiency. Am J Med Genet A 2006;140:62–9.PubMedGoogle Scholar
  42. 42.
    Somaschini M, Nogee LM, Sassi I, Danhaive O, Presi S, Boldrini R, Montrasio C, Ferrari M, Wert SE, Carrera P. Unexplained neonatal respiratory distress due to congenital surfactant deficiency. J Pediatr 2007;150:649–53, 653 e641.Google Scholar
  43. 43.
    Pilot-Matias TJ, Kister SE, Fox JL, Kropp K, Glasser SW, Whitsett JA. Structure and organization of the gene encoding human pulmonary surfactant proteolipid SP-B. DNA 1989;8:75–86.PubMedGoogle Scholar
  44. 44.
    Weaver TE. Synthesis, processing and secretion of surfactant proteins B and C. Biochim Biophys Acta 1998;1408:173–9.PubMedGoogle Scholar
  45. 45.
    Ueno T, Linder S, Na CL, Rice WR, Johansson J, Weaver TE. Processing of pulmonary surfactant protein B by napsin and cathepsin H. J Biol Chem 2004;279:16178–84.PubMedCrossRefGoogle Scholar
  46. 46.
    Brasch F, Ochs M, Kahne T, Guttentag S, Schauer-Vukasinovic V, Derrick M, Johnen G, Kapp N, Muller KM, Richter J, et al. Involvement of napsin A in the C- and N-terminal processing of surfactant protein B in type-II pneumocytes of the human lung. J Biol Chem 2003;278:49006–14.PubMedCrossRefGoogle Scholar
  47. 47.
    Brasch F, Ten Brinke A, Johnen G, Ochs M, Kapp N, Muller KM, Beers MF, Fehrenbach H, Richter J, Batenburg JJ, et al. Involvement of cathepsin H in the processing of the hydrophobic surfactant-associated protein C in type II pneumocytes. Am J Respir Cell Mol Biol 2002;26:659–70.PubMedGoogle Scholar
  48. 48.
    Lin Z, Wang G, Demello DE, Floros J. An alternatively spliced surfactant protein B mRNA in normal human lung: Disease implication. Biochem J 1999;343(Pt 1):145–9.PubMedCrossRefGoogle Scholar
  49. 49.
    Wang G, Christensen ND, Wigdahl B, Guttentag SH, Floros J. Differences in N-linked glycosylation between human surfactant protein-B variants of the C or T allele at the single-nucleotide polymorphism at position 1580: Implications for disease. Biochem J 2003;369:179–84.PubMedCrossRefGoogle Scholar
  50. 50.
    Hamvas A, Wegner DJ, Carlson CS, Bergmann KR, Trusgnich MA, Fulton L, Kasai Y, An P, Mardis ER, Wilson RK, et al. Comprehensive genetic variant discovery in the surfactant protein B gene. Pediatr Res 2007;62:170–5.PubMedCrossRefGoogle Scholar
  51. 51.
    Hallman M, Haataja R, Marttila R. Surfactant proteins and genetic predisposition to respiratory distress syndrome. Semin Perinatol 2002;26:450–60.PubMedCrossRefGoogle Scholar
  52. 52.
    Floros J, Veletza SV, Kotikalapudi P, Krizkova L, Karinch AM, Friedman C, Buchter S, Marks K. Dinucleotide repeats in the human surfactant protein-B gene and respiratory-distress syndrome. Biochem J 1995;305(Pt 2):583–90.PubMedGoogle Scholar
  53. 53.
    Hamvas A, Wegner DJ, Trusgnich MA, Madden K, Heins H, Liu Y, Rice T, An P, Watkins-Torry J, Cole FS. Genetic variant characterization in intron 4 of the surfactant protein B gene. Hum Mutat 2005;26:494–5.PubMedCrossRefGoogle Scholar
  54. 54.
    Steagall WK, Lin JP, Moss J. The C/A(-18) polymorphism in the surfactant protein B gene influences transcription and protein levels of surfactant protein B. Am J Physiol Lung Cell Mol Physiol 2007;292:L448–53.PubMedCrossRefGoogle Scholar
  55. 55.
    Ballard PL, Nogee LM, Beers MF, Ballard RA, Planer BC, Polk L, deMello DE, Moxley MA, Longmore WJ. Partial deficiency of surfactant protein B in an infant with chronic lung disease. Pediatrics 1995;96:1046–52.PubMedGoogle Scholar
  56. 56.
    Whitsett JA, Nogee LM, Weaver TE, Horowitz AD. Human surfactant protein B: Structure, function, regulation, and genetic disease. Physiol Rev 1995;75:749–57.PubMedGoogle Scholar
  57. 57.
    Klein JM, Thompson MW, Snyder JM, George TN, Whitsett JA, Bell EF, McCray PB Jr., Nogee LM. Transient surfactant protein B deficiency in a term infant with severe respiratory failure. J Pediatr 1998;132:244–8.PubMedCrossRefGoogle Scholar
  58. 58.
    Tredano M, van Elburg RM, Kaspers AG, Zimmermann LJ, Houdayer C, Aymard P, Hull WM, Whitsett JA, Elion J, Griese M, et al. Compound SFTPB 1549C–>GAA (121ins2) and 457delC heterozygosity in severe congenital lung disease and surfactant protein B (SP-B) deficiency. Hum Mutat 1999;14:502–9.PubMedCrossRefGoogle Scholar
  59. 59.
    Nogee LM, Wert SE, Proffit SA, Hull WM, Whitsett JA. Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency. Am J Respir Crit Care Med 2000;161:973–81.PubMedGoogle Scholar
  60. 60.
    Williams GD, Christodoulou J, Stack J, Symons P, Wert SE, Murrell MJ, Nogee LM. Surfactant protein B deficiency: Clinical, histological and molecular evaluation. J Paediatr Child Health 1999;35:214–20.PubMedCrossRefGoogle Scholar
  61. 61.
    Dunbar AE 3rd, Wert SE, Ikegami M, Whitsett JA, Hamvas A, White FV, Piedboeuf B, Jobin C, Guttentag S, Nogee LM. Prolonged survival in hereditary surfactant protein B (SP-B) deficiency associated with a novel splicing mutation. Pediatr Res 2000;48:275–82.PubMedCrossRefGoogle Scholar
  62. 62.
    Somaschini M, Wert S, Mangili G, Colombo A, Nogee L. Hereditary surfactant protein B deficiency resulting from a novel mutation. Intensive Care Med 2000;26:97–100.PubMedCrossRefGoogle Scholar
  63. 63.
    Lin Z, deMello DE, Wallot M, Floros J. An SP-B gene mutation responsible for SP-B deficiency in fatal congenital alveolar proteinosis: Evidence for a mutation hotspot in exon 4. Mol Genet Metab 1998;64:25–35.PubMedCrossRefGoogle Scholar
  64. 64.
    Beers MF, Hamvas A, Moxley MA, Gonzales LW, Guttentag SH, Solarin KO, Longmore WJ, Nogee LM, Ballard PL. Pulmonary surfactant metabolism in infants lacking surfactant protein B. Am J Respir Cell Mol Biol 2000;22:380–91.PubMedGoogle Scholar
  65. 65.
    deMello DE, Heyman S, Phelps DS, Hamvas A, Nogee L, Cole S, Colten HR. Ultrastructure of lung in surfactant protein B deficiency. Am J Respir Cell Mol Biol 1994;11:230–9.PubMedGoogle Scholar
  66. 66.
    Vorbroker DK, Profitt SA, Nogee LM, Whitsett JA. Aberrant processing of surfactant protein C in hereditary SP-B deficiency. Am J Physiol 1995;268:L647–56.PubMedGoogle Scholar
  67. 67.
    Li J, Ikegami M, Na CL, Hamvas A, Espinassous Q, Chaby R, Nogee LM, Weaver TE, Johansson J. N-terminally extended surfactant protein (SP) C isolated from SP-B-deficient children has reduced surface activity and inhibited lipopolysaccharide binding. Biochemistry 2004;43:3891–8.PubMedCrossRefGoogle Scholar
  68. 68.
    Stahlman MT, Besnard V, Wert SE, Weaver TE, Dingle S, Xu Y, von Zychlin K, Olson SJ, Whitsett JA. Expression of ABCA3 in developing lung and other tissues. J Histochem Cytochem 2007;55:71–83.PubMedCrossRefGoogle Scholar
  69. 69.
    Nogee LM, Dunbar AE 3rd, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001;344:573–9.PubMedCrossRefGoogle Scholar
  70. 70.
    Yokota T, Matsumura Y, Ban N, Matsubayashi T, Inagaki N. Heterozygous ABCA3 mutation associated with non-fatal evolution of respiratory distress. Eur J Pediatr 2007;167:691–3.PubMedCrossRefGoogle Scholar
  71. 71.
    Saugstad OD, Hansen TW, Ronnestad A, Nakstad B, Tollofsrud PA, Reinholt F, Hamvas A, Coles FS, Dean M, Wert SE, et al. Novel mutations in the gene encoding ATP binding cassette protein member A3 (ABCA3) resulting in fatal neonatal lung disease. Acta Paediatr 2007;96:185–90.PubMedCrossRefGoogle Scholar
  72. 72.
    Kunig AM, Parker TA, Nogee LM, Abman SH, Kinsella JP. ABCA3 deficiency presenting as persistent pulmonary hypertension of the newborn. J Pediatr 2007;151:322–4.PubMedCrossRefGoogle Scholar
  73. 73.
    Doan ML, Guillerman RP, Dishop MK, Nogee LM, Langston C, Mallory GB, Sockrider MM, Fan LL. Clinical, radiologic, and pathologic features of ABCA3 mutations in children. Thorax 2008;63(4):366–73.PubMedCrossRefGoogle Scholar
  74. 74.
    Bullard JE, Nogee LM. Heterozygosity for ABCA3 mutations modifies the severity of lung disease associated with a surfactant protein C gene (SFTPC) mutation. Pediatr Res 2007;62:176–9.PubMedCrossRefGoogle Scholar
  75. 75.
    Bullard JE, Wert SE, Nogee LM. ABCA3 deficiency: Neonatal respiratory failure and interstitial lung disease. Semin Perinatol 2006;30:327–34.PubMedCrossRefGoogle Scholar
  76. 76.
    Brasch F, Schimanski S, Muhlfeld C, Barlage S, Langmann T, Aslanidis C, Boettcher A, Dada A, Schroten H, Mildenberger E, et al. Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency. Am J Respir Crit Care Med 2006;174:571–80.PubMedCrossRefGoogle Scholar
  77. 77.
    Edwards V, Cutz E, Viero S, Moore AM, Nogee L. Ultrastructure of lamellar bodies in congenital surfactant deficiency. Ultrastruct Pathol 2005;29:503–9.PubMedCrossRefGoogle Scholar
  78. 78.
    Bruder E, Hofmeister J, Aslanidis C, Hammer J, Bubendorf L, Schmitz G, Rufle A, Buhrer C. Ultrastructural and molecular analysis in fatal neonatal interstitial pneumonia caused by a novel ABCA3 mutation. Mod Pathol 2007;20:1009–18.PubMedCrossRefGoogle Scholar
  79. 79.
    Matsumura Y, Ban N, Ueda K, Inagaki N. Characterization and classification of ATP-binding cassette transporter ABCA3 mutants in fatal surfactant deficiency. J Biol Chem 2006;281:34503–14.PubMedCrossRefGoogle Scholar
  80. 80.
    Cutz E, Wert SE, Nogee LM, Moore AM. Deficiency of lamellar bodies in alveolar type II cells associated with fatal respiratory disease in a full-term infant. Am J Respir Crit Care Med 2000;161:608–14.PubMedGoogle Scholar
  81. 81.
    Tryka AF, Wert SE, Mazursky JE, Arrington RW, Nogee LM. Absence of lamellar bodies with accumulation of dense bodies characterizes a novel form of congenital surfactant defect. Pediatr Dev Pathol 2000;3:335–45.PubMedCrossRefGoogle Scholar
  82. 82.
    deMello DE, Nogee LM, Heyman S, Krous HF, Hussain M, Merritt TA, Hsueh W, Haas JE, Heidelberger K, Schumacher R, et al. Molecular and phenotypic variability in the congenital alveolar proteinosis syndrome associated with inherited surfactant protein B deficiency. J Pediatr 1994;125:43–50.PubMedCrossRefGoogle Scholar
  83. 83.
    Nogee LM, de Mello DE, Dehner LP, Colten HR. Brief report: Deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 1993;328:406–10.Google Scholar
  84. 84.
    Clark JC, Wert SE, Bachurski CJ, Stahlman MT, Stripp BR, Weaver TE, Whitsett JA. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci USA 1995;92:7794–8.PubMedCrossRefGoogle Scholar
  85. 85.
    Fitzgerald ML, Xavier R, Haley KJ, Welti R, Goss JL, Brown CE, Zhuang DZ, Bell SA, Lu N, McKee M, et al. ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerol. J Lipid Res 2007;48:621–32.PubMedCrossRefGoogle Scholar
  86. 86.
    Cheong N, Zhang H, Madesh M, Zhao M, Yu K, Dodia C, Fisher AB, Savani RC, Shuman H. ABCA3 is critical for lamellar body biogenesis in vivo. J Biol Chem 2007;282:23811–7.PubMedCrossRefGoogle Scholar
  87. 87.
    Ban N, Matsumura Y, Sakai H, Takanezawa Y, Sasaki M, Arai H, Inagaki N. ABCA3 as a lipid transporter in pulmonary surfactant biogenesis. J Biol Chem 2007;282:9628–34.PubMedCrossRefGoogle Scholar
  88. 88.
    Hammel M, Michel G, Hoefer C, Klaften M, Muller-Hocker J, de Angelis MH, Holzinger A. Targeted inactivation of the murine Abca3 gene leads to respiratory failure in newborns with defective lamellar bodies. Biochem Biophys Res Commun 2007;359:947–51.PubMedCrossRefGoogle Scholar
  89. 89.
    Stahlman MT, Gray MP, Falconieri MW, Whitsett JA, Weaver TE. Lamellar body formation in normal and surfactant protein B-deficient fetal mice. Lab Invest 2000;80:395–403.PubMedGoogle Scholar
  90. 90.
    Melton KR, Nesslein LL, Ikegami M, Tichelaar JW, Clark JC, Whitsett JA, Weaver TE. SP-B deficiency causes respiratory failure in adult mice. Am J Physiol Lung Cell Mol Physiol 2003;285:L543–49.PubMedGoogle Scholar
  91. 91.
    Tokieda K, Iwamoto HS, Bachurski C, Wert SE, Hull WM, Ikeda K, Whitsett JA. Surfactant protein-B-deficient mice are susceptible to hyperoxic lung injury. Am J Respir Cell Mol Biol 1999;21:463–72.PubMedGoogle Scholar
  92. 92.
    Pryhuber GS, Bachurski C, Hirsch R, Bacon A, Whitsett JA. Tumor necrosis factor-alpha decreases surfactant protein B mRNA in murine lung. Am J Physiol 1996;270:L714–21.PubMedGoogle Scholar
  93. 93.
    Pryhuber GS, Khalak R, Zhao Q. Regulation of surfactant proteins A and B by TNF-alpha and phorbol ester independent of NF-kappa B. Am J Physiol 1998;274:L289–95.PubMedGoogle Scholar
  94. 94.
    Greene KE, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, Wong WB, Hull W, Whitsett JA, Akino T, Kuroki Y, et al. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 1999;160:1843–50.PubMedGoogle Scholar
  95. 95.
    Ingenito EP, Mora R, Cullivan M, Marzan Y, Haley K, Mark L, Sonna LA. Decreased surfactant protein-B expression and surfactant dysfunction in a murine model of acute lung injury. Am J Respir Cell Mol Biol 2001;25:35–44.PubMedGoogle Scholar
  96. 96.
    Herman TE, Nogee LM, McAlister WH, Dehner LP. Surfactant protein B deficiency: Radiographic manifestations. Pediatr Radiol 1993;23:373–5.PubMedCrossRefGoogle Scholar
  97. 97.
    Newman B, Kuhn JP, Kramer SS, Carcillo JA. Congenital surfactant protein B deficiency–emphasis on imaging. Pediatr Radiol 2001;31:327–31.PubMedCrossRefGoogle Scholar
  98. 98.
    Karjalainen MK, Haataja R, Hallman M. Haplotype analysis of ABCA3: Association with respiratory distress in very premature infants. Ann Med 2008;40:56–65.PubMedCrossRefGoogle Scholar
  99. 99.
    Sen P, Thakur N, Stockton DW, Langston C, Bejjani BA. Expanding the phenotype of alveolar capillary dysplasia (ACD). J Pediatr 2004;145:646–51.PubMedCrossRefGoogle Scholar
  100. 100.
    Wegner DJ, Hertzberg T, Heins HB, Elmberger G, MacCoss MJ, Carlson CS, Nogee LM, Cole FS, Hamvas A. A major deletion in the surfactant protein-B gene causing lethal respiratory distress. Acta Paediatr 2007;96:516–20.PubMedCrossRefGoogle Scholar
  101. 101.
    Langston C, Patterson K, Dishop MK, Askin F, Baker P, Chou P, Cool C, Coventry S, Cutz E, Davis M, et al. A protocol for the handling of tissue obtained by operative lung biopsy: Recommendations of the chILD pathology co-operative group. Pediatr Dev Pathol 2006;9:173–80.PubMedCrossRefGoogle Scholar
  102. 102.
    Hamvas A, Cole FS, deMello DE, Moxley M, Whitsett JA, Colten HR, Nogee LM. Surfactant protein B deficiency: Antenatal diagnosis and prospective treatment with surfactant replacement. J Pediatr 1994;125:356–61.PubMedCrossRefGoogle Scholar
  103. 103.
    Moulton SL, Krous HF, Merritt TA, Odell RM, Gangitano E, Cornish JD. Congenital pulmonary alveolar proteinosis: Failure of treatment with extracorporeal life support. J Pediatr 1992;120:297–302.PubMedCrossRefGoogle Scholar
  104. 104.
    Hamvas A, Nogee LM, Mallory GB Jr., Spray TL, Huddleston CB, August A, Dehner LP, deMello DE, Moxley M, Nelson R, et al. Lung transplantation for treatment of infants with surfactant protein B deficiency. J Pediatr 1997;130:231–9.PubMedCrossRefGoogle Scholar
  105. 105.
    Palomar LM, Nogee LM, Sweet SC, Huddleston CB, Cole FS, Hamvas A. Long-term outcomes after infant lung transplantation for surfactant protein B deficiency related to other causes of respiratory failure. J Pediatr 2006;149:548–53.PubMedCrossRefGoogle Scholar
  106. 106.
    Yoshida I, Ban N, Inagaki N. Expression of ABCA3, a causative gene for fatal surfactant deficiency, is up-regulated by glucocorticoids in lung alveolar type II cells. Biochem Biophys Res Commun 2004;323:547–55.PubMedCrossRefGoogle Scholar
  107. 107.
    Barbato A, Panizzolo C. Chronic interstitial lung disease in children. Paediatr Respir Rev 2000;1:172–8.PubMedCrossRefGoogle Scholar
  108. 108.
    Stuhrmann M, Bohnhorst B, Peters U, Bohle RM, Poets CF, Schmidtke J. Prenatal diagnosis of congenital alveolar proteinosis (surfactant protein B deficiency). Prenat Diagn 1998;18:953–5.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Lawrence M. Nogee
    • 1
  1. 1.Department of PediatricsJohns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations